Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by sweenbyon Nov 11, 2010 8:30am

271 Views

Post# 17691282

Insider

Halo Resources Ltd. (HLO)						As of November 10th, 2010
Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	# or value acquired or disposed of	Unit Price
Nov 10/10	Nov 06/10	Joe Dwek Management Consultants 2007 Inc.	Control or Direction	Warrants	55 - Expiration of warrants	-43,730
Nov 10/10	Nov 06/10	Joe Dwek Management Consultants 2007 Inc.	Control or Direction	Options	52 - Expiration of options	-174,921
Nov 10/10	Sep 03/10	Joe Dwek Management Consultants 2007 Inc.	Control or Direction	Options	37 - Stock split or consolidation	-2,487,793
Nov 10/10	Sep 03/10	Joe Dwek Management Consultants 2007 Inc.	Control or Direction	Warrants	37 - Stock split or consolidation	-393,573
Nov 09/10	Nov 06/10	Joe Dwek Management Consultants 2007 Inc.	Control or Direction	Warrants	55 - Expiration of warrants	-874,607